Abstract
Anti-D IgG was injected into 15 Rh-negative women in the 28th week of gestation and into three non-pregnant women. The uptake of anti-D after the intramuscular injections was calculated by measuring the concentration of antibody in the plasma with an autoanalyser. The biological half life and the catabolic rate of anti-D IgG were calculated according to a compartmental model. The recovery in vivo of anti-D was an average 24% in the non-pregnant women and 21% in the pregnant women. The half life of anti-D were 24 and 21 days, respectively. With a dose of 125 micrograms the plasma anti-D concentration was less than 1 ng/ml at about 10 weeks after the injection. With double the dose the concentration at delivery was at least 1 ng/ml. Although 250 micrograms of anti-D IgG seems to be effective when given in the 28th weeks of gestation, the great individual variations in uptake and recovery rates will lead to occasional cases of Rh-immunisation during pregnancy despite all routine regimens.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BARANDUN S. DIE GAMMAGLOBULIN-THERAPIE. CHEMISCHE, IMMUNOLOGISCHE UND KLINISCHE GRUNDLAGEN. Bibl Haematol. 1964;17:SUPPL–SUPP134. [PubMed] [Google Scholar]
- Bowman J. M., Chown B., Lewis M., Pollock J. M. Rh isoimmunization during pregnancy: antenatal prophylaxis. Can Med Assoc J. 1978 Mar 18;118(6):623–627. [PMC free article] [PubMed] [Google Scholar]
- Bowman J. M., Pollock J. M. Antenatal prophylaxis of Rh isoimmunization: 28-weeks'-gestation service program. Can Med Assoc J. 1978 Mar 18;118(6):627–630. [PMC free article] [PubMed] [Google Scholar]
- COHEN S., FREEMAN T. Metabolic heterogeneity of human gamma-globulin. Biochem J. 1960 Sep;76:475–487. doi: 10.1042/bj0760475. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hermann M., Kjellman H. Rh-prophylaxis with immunoglobulin anti-D administered during pregnancy and after delivery. Acta Obstet Gynecol Scand Suppl. 1976;49:1–11. doi: 10.3109/00016347609156436. [DOI] [PubMed] [Google Scholar]
- Hughes-Jones N. C., Stevenson M. The anti-D content of IgG preparations for use in the prevention of Rh haemolytic disease. Vox Sang. 1968;14(6):401–408. doi: 10.1111/j.1423-0410.1968.tb01732.x. [DOI] [PubMed] [Google Scholar]
- Hutchins C. J. Plasma volume changes in pregnancy in Indian and European primigravidae. Br J Obstet Gynaecol. 1980 Jul;87(7):586–589. doi: 10.1111/j.1471-0528.1980.tb05009.x. [DOI] [PubMed] [Google Scholar]
- Jouvenceaux A. Prévention de l'immunisation anti-Rh. Rev Fr Transfus. 1971 Mar;14(1):39–52. doi: 10.1016/s0035-2977(71)80004-4. [DOI] [PubMed] [Google Scholar]
- MARTIN DU PAN R., SCHEIDEGGER J. J., WENGER P., KOECHLI B., ROUX J. Das Verhalten der Intramuskulär, intravenös und per os verabreichten Gammaglobuline. Blut. 1959 Apr;5(2):104–114. doi: 10.1007/BF01630314. [DOI] [PubMed] [Google Scholar]
- Morell A., Schürch B., Ryser D., Hofer F., Skvaril F., Barandun S. In vivo behaviour of gamma globulin preparations. Vox Sang. 1980;38(5):272–283. doi: 10.1111/j.1423-0410.1980.tb02367.x. [DOI] [PubMed] [Google Scholar]
- STURGEON P., CEDERGREN B., MCQUISTON D. AUTOMATION OF ROUTINE BLOODTYPING PROCEDURES. Vox Sang. 1963 Jul-Aug;8:438–451. doi: 10.1111/j.1423-0410.1963.tb04163.x. [DOI] [PubMed] [Google Scholar]
- Smith G. N., Griffiths B., Mollison D., Mollison P. L. Uptake of IgG after intramuscular and subcutaneous injection. Lancet. 1972 Jun 3;1(7762):1208–1212. doi: 10.1016/s0140-6736(72)90926-9. [DOI] [PubMed] [Google Scholar]